• Menu
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Before Header

Michelle's blog

Food allergy and food intolerance, freefrom foods, electrosensitivity, this and that...

  • Home
  • Blog
  • About
  • FreeFrom Food Awards
  • Foods Matter
  • Walks & Gardens
  • Salon Music
  • Home
  • Blog
  • About
  • FreeFrom Food Awards
  • Foods Matter
  • Walks & Gardens
  • Salon Music

Good news for those with peanut allergy

21/12/2020 //  by Michelle Berridale Johnson//  Leave a Comment

The news may be grim on the virus front but there have been two bits of good news this month for those with peanut allergy.

Earlier in the month The Journal of Allergy and Immunology: In Practice reported on on a trial which demonstrated that peanut oral immunotherapy is still effective after one year of maintenance in children from 7 months to 6 years old.

A total of 117 of the 161 eligible patients completed the trial and received the follow-up. Among them, 92 (78.6%) were able to tolerate a cumulative peanut protein dose of 4,000mg – around 28 peanuts. A total of 115 (98.3%) tolerated a cumulative 1,000mg dose (7 peanuts). This would most certainly protect them against accidental peanut exposures – thus easing greatest concern of the parents of peanut allergic children.

Worth noting was the fact that adrenaline/epinephrine was only needed by two participants during the maintenance phase, only one patient needed to go to the emergency department due to an allergic reaction and only 10.5% of participants experienced any allergic reactions at all.

And then today I received a press release announcing that Aimmune Therapeutics’ PALFORZIA drug has now received approval for use across Europe. PALFORZIA, to quote the press release is:

‘…a complex biologic drug used with a structured dosing approach that builds on a century of oral immunotherapy (OIT) research. With OIT, the specific allergenic proteins are ingested initially in very small quantities, followed by incrementally increasing amounts, that can result in the ability to mitigate allergic reactions to the allergen over time. PALFORZIA is a rigorously developed, pharmaceutical-grade OIT for peanut allergy with a well-defined allergen profile to assure the consistency of every dose, from 0.5 mg (equivalent to 1/600th of a peanut) to 300 mg.’

PALFORZIA has undergone very similar trials to those reported in the JACI with very similar outcomes. For more information on the PALISADE trial see the New England Journal of Medicine here and for the ARTEMIS trial see PubMed here.

“Results from landmark Phase 3 clinical trials have shown more than half of patients treated with PALFORZIA were able to tolerate the equivalent of seven to eight peanut kernels after up to nine months of treatment. These compelling data highlight its potential to mitigate against severe allergic reactions, including anaphylaxis in the event of unintended exposure to peanut protein,” said Prof. George du Toit, Professor of Paediatric Allergy at Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust.

However, while this is very good news for the long term treatment and management of peanut (and possibly other) allergies, those with peanut allergies (and parents of peanut allergic children) must remember that the treatment ‘is not intended for, and does not provide, immediate relief of allergic symptoms….’ It should not be used for emergency treatment of allergic reactions when adrenaline should always be available and be used.

close

Check your inbox or spam folder to confirm your subscription.

Category: Allergies, Peanut allergyTag: Aimmune Therapeutics, Aimmune Therapies PALFORZIA, ARTEMIS peanut allergy trial, OIT for peanut allergy, Oral immunotherapy, PALFORZIA, PALISADE peanut allergy trial, Peanut/treenut allergy, Prof. George du Toit, The Journal of Allergy and Immunology: In Practice

Previous Post: « Is it time to subject Vitamin C to serious scientific scrutiny?
Next Post: Happy, if distanced, Christmas! »

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • #Speak Up for Allergies
  • Novel food proteins – do they pose a risk to food allergics?
  • The dairy wars
  • In memory of Pat Schooling
  • FSA – on the allergy case

Search this blog

ARCHIVES

Blogroll

  • Allergy Insight
  • Better brains, naturally
  • For Ever FreeFrom
  • Free From (gluten)
  • Freefrom Food Awards
  • Gluten-free Mrs D
  • Natural Health Worldwide
  • Pure Health Clinic
  • Skins Matter
  • The Helminthic Therapy Wiki
  • Truly Gluten Free
  • What Allergy?

TOPICS

FSA – on the allergy case

You might well have thought that COVID concerns had taken over all branches of government activity – but not so. The Foods Standards Agency, while noting the issues, has refused to be distracted from its Food Hypersensitivity work. What is also good to realise – although I suspect that few do – is that all …

Homeopathy – a second string to our vaccination bow?

Cuba has always had a very individualistic– and on the whole very successful – approach to public and population health. The hard line socialist nature of their politics, especially in early days after the revolution, resulted in very high levels of education and medical care – but also in isolation from much of the developed …

Sad, sad news

Yesterday evening, Lisa Acton – co founder, with her husband John Burke, of the Irish FreeFrom Food Awards – finally lost a long and heroic battle with cancer. To my regret I had only met her a few times. A couple of years ago when John brought the whole family to a FreeFrom Food Awards …

Are COVID vaccines safe for those with allergies?

Allergy reactors are, understandably, worried as to whether they should accept a vaccination if and when it is offered. After consultation with the BSACI (British Society for Allergy and Clinical Immunology) the MHRA (Medicines  and Healthcare products Regulatory Agency) have updated their original warning that those with allergies to vaccines, drugs and food should not …

Disastrous Brexit fallout for medical cannabis users

Thanks to the tireless campaigning of a group of  ‘epilepsy mothers’, lead by Hannah Deacon, the mother of Alfie Dingley, and her consultant, neurologist Professor Mike Barnes, a change in the law in 2018 allowed the prescription of medical cannabis for children with certain rare types of epilepsy, those in chronic pain and for those …

The trouble about gluten-free oats

Oats are delicious – oats are nutritious – they contain high levels of vitamins, minerals and antioxidants and are an excellent source of fibre – they do not contain the protein gliadin, the gluten fraction that coeliacs need to avoid – they add texture to gluten free baking and are easy to cook with. Few …

Copyright © 2021 · Michelle's Blog · Michelle Berridale Johnson · Site design by DigitalJen·